GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of SELECT — 9 things I got wrong before I got it right — 25 comments in the full submission. View in context.
660
c/trialwatch·submitted 1 year ago by u/piotr_bruun

SELECT — 9 things I got wrong before I got it right

Readoutbranch of 9 comments

STEP. That is the whole post, but I will justify it. Everything else people worry about in c/orforglipron is downstream of it. Titration speed, muscle cramps, the endless dose arguments — most of it resolves if you sort STEP out first, and almost nobody does. I say this having got it wrong for 18 months. My…

Read the full submission and all 25 comments →

This branch

9 comments, started 1 year ago
u/yara_mensah53 points·1 year ago

Phase 2 or phase 3?

replysharereportpermalink
u/trialwatch_theoMOD36 points·1 year ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/marit_laurent25 points·1 year ago

What was the dropout rate?

replysharereportpermalink
load more comments (2) →
u/rulebook_rachaelmod · c/meta16 points·1 year ago·edited

the 16 week readout is different from the 5 week readout

replysharereportpermalink
u/ines_castellanos19 points·1 year ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/injection_site_iris6 points·1 year ago·edited

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/joaquin_trevino2 points·1 year ago

give the trial name, phase, n, and primary endpoint in the body

Yes, exactly this, and it is the bit that took me 6 weeks to accept.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →